Rosavins, salidroside, and standardization
Rhodiola rosea is an arctic plant whose extracts are usually standardized to two marker groups: the rosavins (rosavin, rosin, rosarin) and salidroside. A commonly cited target ratio in research-grade extracts is roughly 3 to 1 rosavins to salidroside, mirroring the proportion found in the root. Because cheaper products may be standardized differently or use other Rhodiola species, the marker content matters for comparing studies.
Monoamine tone and HPA reactivity under stress
Rhodiola is studied for two overlapping actions. It is proposed to influence monoamine neurotransmitters, including effects on serotonin and dopamine signaling, and to modulate the HPA axis so the cortisol response to a stressor is better contained. Together these are framed as increased stress resilience, often reported in trials as reduced fatigue under demanding conditions.
Human trials are mostly small and of variable quality, so benefits should be read as modest and preliminary. This is general educational information, not medical advice. Rhodiola has stimulating qualities for some people and may interact with antidepressants and other medication, so consult a qualified professional before use.